View in EDS

Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.

Saved in:
Bibliographic Details
Title: Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
Authors: Crawford N; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Stott KJ; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Sessler T; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., McCann C; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., McDaid W; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Lees A; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Latimer C; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Fox JP; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Munck JM; Astex Pharmaceuticals, Cambridge, United Kingdom., Smyth T; Astex Pharmaceuticals, Cambridge, United Kingdom., Shah A; Astex Pharmaceuticals, Cambridge, United Kingdom., Martins V; Astex Pharmaceuticals, Cambridge, United Kingdom., Lawler M; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Dunne PD; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Kerr EM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., McDade SS; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Coyle VM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Longley DB; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom. d.longley@qub.ac.uk.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Sep; Vol. 20 (9), pp. 1627-1639. Date of Electronic Publication: 2021 Aug 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34389694
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Crawford+N%22">Crawford N</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stott+KJ%22">Stott KJ</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sessler+T%22">Sessler T</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McCann+C%22">McCann C</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McDaid+W%22">McDaid W</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lees+A%22">Lees A</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Latimer+C%22">Latimer C</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fox+JP%22">Fox JP</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Munck+JM%22">Munck JM</searchLink>; Astex Pharmaceuticals, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Smyth+T%22">Smyth T</searchLink>; Astex Pharmaceuticals, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Shah+A%22">Shah A</searchLink>; Astex Pharmaceuticals, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martins+V%22">Martins V</searchLink>; Astex Pharmaceuticals, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lawler+M%22">Lawler M</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dunne+PD%22">Dunne PD</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kerr+EM%22">Kerr EM</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McDade+SS%22">McDade SS</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coyle+VM%22">Coyle VM</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Longley+DB%22">Longley DB</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom. d.longley@qub.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2021 Sep; Vol. 20 (9), pp. 1627-1639. <i>Date of Electronic Publication: </i>2021 Aug 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34389694
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-20-1050
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1627
    Titles:
      – TitleFull: Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Crawford N
      – PersonEntity:
          Name:
            NameFull: Stott KJ
      – PersonEntity:
          Name:
            NameFull: Sessler T
      – PersonEntity:
          Name:
            NameFull: McCann C
      – PersonEntity:
          Name:
            NameFull: McDaid W
      – PersonEntity:
          Name:
            NameFull: Lees A
      – PersonEntity:
          Name:
            NameFull: Latimer C
      – PersonEntity:
          Name:
            NameFull: Fox JP
      – PersonEntity:
          Name:
            NameFull: Munck JM
      – PersonEntity:
          Name:
            NameFull: Smyth T
      – PersonEntity:
          Name:
            NameFull: Shah A
      – PersonEntity:
          Name:
            NameFull: Martins V
      – PersonEntity:
          Name:
            NameFull: Lawler M
      – PersonEntity:
          Name:
            NameFull: Dunne PD
      – PersonEntity:
          Name:
            NameFull: Kerr EM
      – PersonEntity:
          Name:
            NameFull: McDade SS
      – PersonEntity:
          Name:
            NameFull: Coyle VM
      – PersonEntity:
          Name:
            NameFull: Longley DB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1